📰 Accelerate Diagnostics News
Page 11 - Accelerate Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accelerate Diagnostics. Real-time updates on events, politics, business and more.
July 25, 2022
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, August 15, 2022, at 4:30 p.m....
July 11, 2022
Commercialization of the Accelerate Arc system, which includes the Accelerate Arc Module and BC kit, unlocks the path to automated, rapid microbial identification (ID) for positive blood cultures across the large installed base of MALDI system users. The Accelerate Arc system can cut hours of wait time, eliminate la...
July 11, 2022
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...
June 21, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...
June 21, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...
June 19, 2022
Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 65.5% of Accelerate Diagnostics shares […]
June 1, 2022
Of the 30 diagnostic companies in the index, 13 saw their share prices increase, while 17 saw stock prices decline.
May 23, 2022
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, will present at the 42nd Annual...
May 17, 2022
TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Monday reported a loss of...
May 16, 2022
The firm said the new workflow eliminates the need to batch multiple specimen tests, cutting hours off the wait for microbial ID results for positive blood cultures.